MedTrace Logo

Nutritional and Physical Exercise Intervention in Older Patients With Malignant Hemopathies

NCT04057443 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-08-30

No results posted yet for this study

Summary

Clinical trial to analyze the impact of nutrition and physical exercise intervention program on the completion of treatment in older patients 70 years or older with malignant hemopathology

Conditions

  • Hematologic Malignancy
  • Old Age; Debility

Interventions

OTHER

Nutritional support

Nutritional support will be given to all patients according with their nutritional body composition parameters (Nutritional assessment and sarcopenia evaluation). It could be diet counselling, oral supplemented nutrition, enteral nutrition o parenteral nutrition.

OTHER

Physical exercise

The exercise program, designed, applied and monitored by research staff of the Physiology Unit, will have duration of 24 weeks (6 months). The program will have a mixed structure, the participants in an individual way fulfill their training and attend group sessions (8 subjects). In addition, 3 days a week should conduct sessions that will focus on the work of balance and general strength.

DRUG

Hematologic Drug

The patients of the control group will follow the standard treatment and follow-up according to the clinical protocol of the institution.

Sponsors & Collaborators

  • Institut d'Investigació Biomèdica de Bellvitge

    collaborator OTHER

  • University of Barcelona

    collaborator OTHER

  • Instituto de Salud Carlos III

    collaborator OTHER_GOV

  • Maite Antonio, MD, Phd

    lead OTHER

Principal Investigators

  • Maite Antonio, MD,PhD · Institut Català d'Oncologia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-11
Primary Completion
2021-06-01
Completion
2023-06-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04057443 on ClinicalTrials.gov